| Literature DB >> 29727618 |
Hiroki Hayashi1, Douglas T Hess1, Rongli Zhang1, Keiki Sugi2, Huiyun Gao2, Bea L Tan3, Dawn E Bowles4, Carmelo A Milano4, Mukesh K Jain5, Walter J Koch6, Jonathan S Stamler7.
Abstract
Most G protein-coupled receptors (GPCRs) signal through both heterotrimeric G proteins and β-arrestins (βarr1 and βarr2). Although synthetic ligands can elicit biased signaling by G protein- vis-à-vis βarr-mediated transduction, endogenous mechanisms for biasing signaling remain elusive. Here we report that S-nitrosylation of a novel site within βarr1/2 provides a general mechanism to bias ligand-induced signaling through GPCRs by selectively inhibiting βarr-mediated transduction. Concomitantly, S-nitrosylation endows cytosolic βarrs with receptor-independent function. Enhanced βarr S-nitrosylation characterizes inflammation and aging as well as human and murine heart failure. In genetically engineered mice lacking βarr2-Cys253 S-nitrosylation, heart failure is exacerbated in association with greatly compromised β-adrenergic chronotropy and inotropy, reflecting βarr-biased transduction and β-adrenergic receptor downregulation. Thus, S-nitrosylation regulates βarr function and, thereby, biases transduction through GPCRs, demonstrating a novel role for nitric oxide in cellular signaling with potentially broad implications for patho/physiological GPCR function, including a previously unrecognized role in heart failure.Entities:
Keywords: G protein-coupled receptor; GPCR bias; S-nitrosylation; angiotensin receptor; arrestin; heart failure; nitric oxide; nitric oxide synthase; β-adrenergic receptor; β-arrestin dimerization
Mesh:
Substances:
Year: 2018 PMID: 29727618 PMCID: PMC5940012 DOI: 10.1016/j.molcel.2018.03.034
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970